121-135 of 232
COVID-19 Vaccines & Considerations for Approval
Perspectives with the AMACOVID-19 Vaccines & Considerations for Approval
Charles Turck, PharmD, BCPS, BCCCP
Mira Irons, MD
Shannon Curtis
John Russell, MD
John Russell, MD
William G. Callahan, DO
Exploring the Treatment Landscape for Head & Neck Cancer
Project Oncology®Exploring the Treatment Landscape for Head & Neck Cancer
Jacob Sands, MD
Nabil F. Saba, MD, FACP
Assessing the Asthma Management Guideline Updates
The Drug ReportAssessing the Asthma Management Guideline Updates
Linda Bernstein, Pharm.D.
John Russell, MD
- advertisement
NTM Lung Disease: Management Strategies and Importance of Lung Wellness
Deep Breaths: Updates from CHESTNTM Lung Disease: Management Strategies and Importance of Lung Wellness
Megan Carreon, MHA, RRT
Amy Levinger, MSN, FNP-C
Timothy Aksamit, MD
John Russell, MD
Progress in Peanut Allergy: What to Know About the First FDA-Approved Treatment
The Drug ReportProgress in Peanut Allergy: What to Know About the First FDA-Approved Treatment
Linda Bernstein, Pharm.D.
What’s New in COPD Care: Updates to the GOLD Guidelines & Other Advances
Deep Breaths: Updates from CHESTWhat’s New in COPD Care: Updates to the GOLD Guidelines & Other Advances
Nicola A. Hanania, MD, MS, FCCP
Neil J. Freedman, MD
Singling Out Severe Asthma: New Breakthroughs in Treatment
Deep Breaths: Updates from CHESTSingling Out Severe Asthma: New Breakthroughs in Treatment
Sandhya Khurana, MD, FCCP
Monica Kraft, MD, FCCP
Matt Birnholz, MD
Claudette Poole, MD
- advertisement
Dispelling Common Misconceptions About Vaccines
VacciNationDispelling Common Misconceptions About Vaccines
Jennifer Caudle, DO, FACOFP
Barbara Pahud, MD
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
Book ClubThe Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
John Russell, MD
Meredith Wadman, BM, BCh, M.S.
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
AudioAbstractsAnti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
